Cargando…
DNA repair pathways and cisplatin resistance: an intimate relationship
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors. Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its remarkable efficiency, most tumors show intrinsic or acquired drug resistance. The primary biological target of cisplatin is gen...
Autores principales: | Rocha, Clarissa Ribeiro Reily, Silva, Matheus Molina, Quinet, Annabel, Cabral-Neto, Januario Bispo, Menck, Carlos Frederico Martins |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113849/ https://www.ncbi.nlm.nih.gov/pubmed/30208165 http://dx.doi.org/10.6061/clinics/2018/e478s |
Ejemplares similares
-
The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells
por: Silva, Matheus Molina, et al.
Publicado: (2019) -
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
por: Rocha, Clarissa Ribeiro Reily, et al.
Publicado: (2016) -
Editorial: DNA repair and immune response
por: Basso, Paulo José, et al.
Publicado: (2022) -
ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
por: Gomes, Luciana Rodrigues, et al.
Publicado: (2019) -
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
por: Ribeiro Reily Rocha, Clarissa, et al.
Publicado: (2020)